MRS. NANCY JANE BOLLINGER, PT
Physical Therapy at Splendor Way, Indianapolis, IN
License number
Indiana 05007085A
Category
Restorative Service Providers
Type
Physical Therapist
Address
Address
10340 Splendor Way, Indianapolis, IN 46234
Phone
(317) 852-1869
Professional information
Nancy J Bollinger, Indianapolis IN - PT (Physical therapy)
Specialties:
Physical Therapy
Address:
10340 Splendor Way, Indianapolis 46234
(317) 852-1869 (Phone)
(317) 852-1869 (Phone)
Languages:
English
Method Of Treating Endotoxic Shock In Mammals
US Patent:
5294613, Mar 15, 1994
Filed:
Feb 7, 1992
Appl. No.:
7/834181
Inventors:
Nancy G. Bollinger - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3141
US Classification:
514242
Abstract:
This invention provides benzene derivatives, pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.
Anti-Inflammatory Agents
US Patent:
4945099, Jul 31, 1990
Filed:
Jun 5, 1989
Appl. No.:
7/361873
Inventors:
Nancy G. Bollinger - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D25704, A61K 3141, A61K 31275, C07C 4984
US Classification:
514381
Abstract:
This invention provides benzene derivatives, pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.
Anti-Inflammatory Agents
US Patent:
5098613, Mar 24, 1992
Filed:
Jul 11, 1990
Appl. No.:
7/551221
Inventors:
Nancy G. Bollinger - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Theodore Goodson - Indianapolis IN
David K. Herron - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C11C 100, A61K 3141
US Classification:
260413
Abstract:
This invention provides benzene derivatives, pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.